Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
Authors
Keywords
-
Journal
ADDICTION
Volume 109, Issue 1, Pages 128-137
Publisher
Wiley
Online
2013-09-11
DOI
10.1111/add.12353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state
- (2013) Neal L. Benowitz et al. Pharmacogenetics and Genomics
- The Emerging Potential of Pharmacogenetics in Psychiatry
- (2012) Francis E. Lotrich AMERICAN JOURNAL OF PSYCHIATRY
- Interplay of Genetic Risk Factors (CHRNA5-CHRNA3-CHRNB4) and Cessation Treatments in Smoking Cessation Success
- (2012) Li-Shiun Chen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers
- (2012) G. St.Helen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6
- (2012) A. Joseph Bloom et al. HUMAN MOLECULAR GENETICS
- PharmGKB summary
- (2012) Ellen M. McDonagh et al. Pharmacogenetics and Genomics
- Nicotinic acetylcholine receptor variation and response to smoking cessation therapies
- (2012) Andrew W. Bergen et al. Pharmacogenetics and Genomics
- DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5*
- (2011) Timothy B. Baker et al. ADDICTION
- Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
- (2011) Catherine A. Wassenaar et al. JNCI-Journal of the National Cancer Institute
- The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European–Americans
- (2011) Joseph Bloom et al. Pharmacogenetics and Genomics
- Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy
- (2010) C Lerman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
- (2010) Thorgeir E Thorgeirsson et al. NATURE GENETICS
- Genome-wide meta-analyses identify multiple loci associated with smoking behavior
- (2010) NATURE GENETICS
- Meta-analysis and imputation refines the association of 15q25 with smoking quantity
- (2010) Jason Z Liu et al. NATURE GENETICS
- Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD
- (2010) Nancy L. Saccone et al. PLoS Genetics
- A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies
- (2009) Megan E. Piper et al. ARCHIVES OF GENERAL PSYCHIATRY
- Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes
- (2009) Riju Ray et al. JOURNAL OF NEUROGENETICS
- Molecular Genetics of Successful Smoking Cessation
- (2008) George R. Uhl et al. ARCHIVES OF GENERAL PSYCHIATRY
- Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion
- (2008) F Patterson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rate of Nicotine Metabolism and Withdrawal Symptoms in Adolescent Light Smokers
- (2008) M. L. Rubinstein et al. PEDIATRICS
- Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study
- (2008) Robert A. Schnoll et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation